Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Jaeger

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Circulation|January 29, 2003
Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteriesJ Eduardo Sousa, Marco A Costa, Amanda G M R Sousa, et al.
Circulation|January 8, 2003
Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound studyJ Eduardo Sousa, Marco A Costa, Alexandre Abizaid, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2012
Rapid decline in episodic memory in healthy older adults with high amyloid-βYen Ying Lim, Robert H Pietrzak, Kathryn A Ellis, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|April 5, 2013
Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS)Yen Ying Lim, Judith Jaeger, Karra Harrington, et al.
Journal of Medical Internet Research|June 12, 2025
Temporal Dynamics of Subtle Cognitive Change: Validation of a User-Friendly Multidomain Digital Assessment Using an Alcohol ChallengeJohn Frederick Dyer, Florentine Marie Barbey, Ayan Ghoshal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 22, 2025
Evaluation of cognitive, functional, and behavioral effects observed in EMERGE, a phase 3 trial of aducanumab in people with early Alzheimer's diseaseJeffrey Cummings, Sharon Cohen, Jennifer Murphy, et al.
Biological Psychiatry|May 3, 2011
Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disordersCameron S Carter, Deanna M Barch, Edward Bullmore, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 10, 2021
Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's diseaseAndrew J Aschenbrenner, R Asaad Baksh, Bessy Benejam, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 5, 2024
Methods for Neuroscience Drug Development: Guidance on Standardization of the Process for Defining Clinical Outcome Strategies in Clinical TrialsSilvia Zaragoza Domingo, Jordi Alonso, Montse Ferrer, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Measuring cognition and function in the preclinical stage of Alzheimer's diseaseSandra Weintraub, Maria C Carrillo, Sarah Tomaszewski Farias, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Circulation|January 29, 2003
Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteriesJ Eduardo Sousa, Marco A Costa, Amanda G M R Sousa, et al.
Circulation|January 8, 2003
Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound studyJ Eduardo Sousa, Marco A Costa, Alexandre Abizaid, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2012
Rapid decline in episodic memory in healthy older adults with high amyloid-βYen Ying Lim, Robert H Pietrzak, Kathryn A Ellis, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|April 5, 2013
Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS)Yen Ying Lim, Judith Jaeger, Karra Harrington, et al.
Journal of Medical Internet Research|June 12, 2025
Temporal Dynamics of Subtle Cognitive Change: Validation of a User-Friendly Multidomain Digital Assessment Using an Alcohol ChallengeJohn Frederick Dyer, Florentine Marie Barbey, Ayan Ghoshal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 22, 2025
Evaluation of cognitive, functional, and behavioral effects observed in EMERGE, a phase 3 trial of aducanumab in people with early Alzheimer's diseaseJeffrey Cummings, Sharon Cohen, Jennifer Murphy, et al.
Biological Psychiatry|May 3, 2011
Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disordersCameron S Carter, Deanna M Barch, Edward Bullmore, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 10, 2021
Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's diseaseAndrew J Aschenbrenner, R Asaad Baksh, Bessy Benejam, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 5, 2024
Methods for Neuroscience Drug Development: Guidance on Standardization of the Process for Defining Clinical Outcome Strategies in Clinical TrialsSilvia Zaragoza Domingo, Jordi Alonso, Montse Ferrer, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Measuring cognition and function in the preclinical stage of Alzheimer's diseaseSandra Weintraub, Maria C Carrillo, Sarah Tomaszewski Farias, et al.
Pageof 7